Patent · US Active

Formulations containing sphinganine

US9913789B2 · kind B2 · utility

0Cited by

7References

16Claims

0Family size

Assignee

EVONIK DEGUSSA GMBH · DE

Inventors

Tim Köhler · Dorsten, DE
Mike Farwick · Essen, DE
Matthias Mentel · Dortmund, DE
Peter Lersch · Oberhausen, DE

Key dates

Filing date	Jul 1, 2014
Grant date	Mar 13, 2018
Priority date	—
Expiry date	Jul 1, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61Q7/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to formulations comprising

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.